cardiogram-pulse-trace-1461880398nt8-300x200-8058917Health coverage gains under the Affordable Care Act were concentrated where they were needed most—among lower-income groups and in the five boroughs of New York City—recently released Census Bureau data show.

Between 2013 (before Obamacare took full effect) and 2016, the number of uninsured New Yorkers below age 65 declined by 884,211, according to Small Area Health Insurance Estimates released on March 28.

Just over half of that drop occurred in New York City, and 56 percent involved people living at or below 200 percent of the federal poverty level, or $50,200 for a family of four.

screen-shot-2018-04-24-at-4-42-46-pm-7651081

This was to be expected, because low-income groups and New York City have had higher uninsured rates than the state as a whole.

The state’s overall uninsured rate dropped by five points, from 12.4 percent in 2013 to 7.1 percent in 2016.

In New York City, the rate dropped six points, from 15.1 percent to 8.9 percent. And among people below 200 percent of poverty, the rate dropped eight points, from 19.5 percent to 11.1 percent.

The county with the highest uninsured rate in both 2013 and 2016 was Queens, at 19.2 percent and 11.3 percent, respectively. Yet that eight-point drop—corresponding to 153,000 more people with insurance—was also the largest of any county.

screen-shot-2018-04-24-at-4-42-27-pm-8487396

The county with the lowest uninsured rate in both years was Saratoga, at 7.3 percent and 4.3 percent respectively.

The Census Bureau makes its estimates based on surveys, and they appear to understate coverage gains among low-income populations.

The bureau’s data shows that the uninsured population eligible for Medicaid dropped by 342,000. That’s less than half the state’s Medicaid enrollment gain of 769,000 from 2013 to 2016, as reported by the U.S. Centers for Medicare & Medicaid Services.

About the Author

Bill Hammond

As the Empire Center’s senior fellow for health policy, Bill Hammond tracks fast-moving developments in New York’s massive health care industry, with a focus on how decisions made in Albany and Washington affect the well-being of patients, providers, taxpayers and the state’s economy.

Read more by Bill Hammond

You may also like

The Attorney General’s MFCU SNAFU

Attorney General Letitia James' latest fight with the Trump administration focuses on New York's Medicaid Fraud Control Unit, a federally funded agency housed in James' office. On T Read More

Healthcare Revelations in the Enacted Budget Financial Plan

The state financial plan published on June 10 disclosed key information about healthcare revenue and spending that lawmakers had not made public when approving the annual budget two weeks before. Read More

Federal Suit Traces Medicaid Fraud to the Top of NYS Government

The Trump administration's latest salvo against Medicaid fraud takes aim at a different kind of target – two high-ranking New York officials along with a major state contractor. A Read More

Healthcare Highlights in the New State Budget

Governor Hochul's focus on affordability seems to have skipped over the healthcare portions of the new state budget. The deal finalized May 27 Read More

Lawmakers Consider Hiking Fees for Filling Prescriptions

UPDATE: The proposal discussed below passed the Assembly Friday evening by an unofficial vote of 133-0. Having previously been approved by the Senate, the bill will head to Governor Hochul's desk for her signature or ve Read More

Budget Deal Reportedly Earmarks $100M for 1199 and Extends MCO Tax

As Governor Hochul and legislative leaders rush to finalize the overdue state budget, outlines of some healthcare-related deals have begun to emerge from the closed-door negotiations. Read More

Albany Wavers on Shutting Down a Medicaid Racket

As Washington threatens to crack down on fraud and abuse in New York's Medicaid program, state legislators are doing their best to demonstrate why federal intervention is needed. A Read More

Getting to the Bottom of the 340B Drug Discount Boondoggle

Some of New York's largest and most prosperous hospitals are reporting rapidly growing amounts of revenue from pharmacy sales – most of it apparently flowing from a controversial drug discount program known as 340B. Read More
Text here